Myomo
MYOMyomo Inc. is a wearable medical robotics company that specializes in myoelectric-controlled upper limb orthoses for individuals with neuromuscular disorders and paralysis.
Earnings
Q3 2026 report
November 9, 2026Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
Myomo Inc. is a wearable medical robotics company that specializes in myoelectric-controlled upper limb orthoses for individuals with neuromuscular disorders and paralysis. The company's core value proposition is providing a non-invasive solution that enables patients with conditions such as stroke, brachial plexus injury, and spinal cord injury to regain functional movement in their arms and hands. Myomo operates a direct-to-patient billing model and partners with clinical facilities to integrate its technology into the standard of care for rehabilitation.
Myomo is a first-mover in the myoelectric upper limb orthosis market, offering the only commercially available device in the U.S. that utilizes a patient's own muscle signals to restore movement to paralyzed limbs.
FAQ
- What is Myomo's market cap?
- Myomo (MYO) has a market capitalization of $55.5M and trades on AMEX.
- Who are Myomo's competitors?
- Myomo's key competitors include Lifeward, Xtant Medical Holdings, Inc., PepGen Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Myomo partner with?
- Myomo's notable partners include Cogmedix, AB Corp, Cleveland Clinic, and others.
- Where is Myomo headquartered?
- Myomo is headquartered in United States of America and employs approximately 106 people. It has been publicly traded since 2017.